Results 141 to 150 of about 266 (157)
Some of the next articles are maybe not open access.
samostalna izložba, Fiac-Pouly sur Loire, France
2017Samostalno predstavljanje na Fiac-Pouly sur Loire u ...
openaire +1 more source
1984
l-(2’-Deoxy-2’-fluoro-β-D-arabinofuranosyl)-5-iodocytosine [FIAC or 2’-fluoro-5-iodo-ara-C] is a potent and selective new anti-herpes virus drug. The anti-herpes simplex virus type 1 (HSV-1) activity depends, at least in part, on the phosphorylation of FIAC by the virus-specified pyrimidine nucleoside kinase.
Carlos Lopez +3 more
openaire +1 more source
l-(2’-Deoxy-2’-fluoro-β-D-arabinofuranosyl)-5-iodocytosine [FIAC or 2’-fluoro-5-iodo-ara-C] is a potent and selective new anti-herpes virus drug. The anti-herpes simplex virus type 1 (HSV-1) activity depends, at least in part, on the phosphorylation of FIAC by the virus-specified pyrimidine nucleoside kinase.
Carlos Lopez +3 more
openaire +1 more source
Kari J. Syrjänen, MD, PhD, FIAC: A Tribute to Our Editor on His 75th Birthday
Acta Cytologica, 2023Ivana Kholová +4 more
openaire +3 more sources
2022 Second International Conference on Computer Science, Engineering and Applications (ICCSEA), 2022
Jwan Najeeb Saeed +2 more
openaire +1 more source
Jwan Najeeb Saeed +2 more
openaire +1 more source
Robert Alexander Barter AM, MD, FRACP, FRCPA, FRCPath, FIAC
Medical Journal of Australia, 2011Toby T Nichols, Ian Hammond
openaire +1 more source
Bevan Harvey Coombes MB BS, DCPM, FRCPA, FIAC, FCAP
Medical Journal of Australia, 2005Howard J Coombes, Andrew H Coombes
openaire +1 more source
Prabodh K. Gupta, MBBS, MD (Path), FIAC Retires
Journal of the American Society of Cytopathology, 2016openaire +1 more source